R. Hehlmann
- Hematology top 1%
- Genetics top 2%
- Rheumatology top 5%
- Oncology
- Molecular Biology
- Co-authors
- Andreas HochhausSusanne SaußeleMichele BaccaraniValentín García‐GutiérrezDelphine RéaP. Le CoutreDragana MilojkovićKimmo Porkka
- Topics
- Chronic Myeloid Leukemia Treatments (15 papers)Chronic Lymphocytic Leukemia Research (10 papers)Eosinophilic Disorders and Syndromes (7 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
R. Hehlmann
26 papers receiving 860 citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Hematology 642
- Genetics 495
- Rheumatology 259
- Oncology 124
- Molecular Biology 102
Countries citing papers authored by R. Hehlmann
This map shows the geographic impact of R. Hehlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hehlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hehlmann more than expected).
Fields of papers citing papers by R. Hehlmann
This network shows the impact of papers produced by R. Hehlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hehlmann. The network helps show where R. Hehlmann may publish in the future.
Co-authorship network of co-authors of R. Hehlmann
This figure shows the co-authorship network connecting the top 25 collaborators of R. Hehlmann. A scholar is included among the top collaborators of R. Hehlmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hehlmann. R. Hehlmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemiabreakdown → | 330 |
| 2 | 3 | |
| 3 | 31 | |
| 4 | 41 | |
| 5 | 35 | |
| 6 | 29 | |
| 7 | 3 | |
| 8 | 1 | |
| 9 | 13 | |
| 10 | 2 | |
| 11 | 4 | |
| 12 | 52 | |
| 13 | 24 | |
| 14 | 2 | |
| 15 | 13 | |
| 16 | 18 | |
| 17 | Analysis and validation of prognostic factors for CML. German CML Study Group. | 23 |
| 18 | 96 | |
| 19 | 24 | |
| 20 | [AIDS: the beginning of a catastrophe?]. | 1 |
About R. Hehlmann
R. Hehlmann is a scholar working on Hematology, Microbiology and Genetics, having authored 28 papers that have together received 887 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Eosinophilic Disorders and Syndromes (7 papers). The work is most often cited by research in Hematology (642 citations), Genetics (495 citations) and Rheumatology (259 citations). R. Hehlmann has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Andreas Hochhaus, Susanne Saußele, Michele Baccarani, Valentín García‐Gutiérrez, Delphine Réa, P. Le Coutre, Dragana Milojković, Kimmo Porkka, H. Jean Khoury and Richard E. Clark. Their work appears in journals such as Blood, Journal of Clinical Microbiology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.